No, antibiotics do not need to be continued at home after discharge.
This patient has completed an adequate course of antimicrobial therapy (12 days total) for acute cholecystitis and is now asymptomatic, so no further antibiotics are indicated.
Rationale Based on Current Guidelines
The 2024 Italian guidelines for intra-abdominal infections provide clear duration recommendations for acute cholecystitis 1:
For Complicated Cholecystitis (which this case represents given the need for escalation to meropenem):
- 4 days of antibiotics if the patient is immunocompetent, not critically ill, AND source control is adequate
- Up to 7 days for immunocompromised or critically ill patients with adequate source control
- Beyond 7 days warrants diagnostic investigation for ongoing infection
Key Decision Points:
Source Control Status:
- If the patient underwent cholecystectomy: Source control is achieved, antibiotics should stop per guideline recommendations
- If managed medically without surgery: The patient has already received 12 days of therapy (5 days ceftriaxone + 7 days meropenem), which exceeds the recommended maximum of 7 days
Clinical Resolution:
- The patient is currently pain-free
- No ongoing signs of infection or systemic illness
- These findings indicate treatment success
Important Caveats
Red flags that would require further investigation (not continuation of antibiotics):
- Persistent fever or abdominal pain
- Elevated inflammatory markers (WBC, CRP, procalcitonin)
- Signs of complications (abscess, perforation, biliary obstruction)
If any of these are present beyond 7 days of therapy, the guidelines explicitly state that diagnostic investigation is warranted 1, not empiric antibiotic continuation.
Gallstones remain in situ: If the patient was managed conservatively without cholecystectomy, they remain at risk for recurrent cholecystitis. However, this is an indication for interval cholecystectomy (typically 6-8 weeks after resolution), not prolonged antibiotic therapy 1.
Clinical Reasoning
The escalation from ceftriaxone to meropenem suggests either:
- Clinical non-response to initial therapy
- Concern for resistant organisms or healthcare-associated infection
- Severe/complicated disease
Despite this escalation, the patient has now completed 12 days of broad-spectrum coverage and achieved clinical resolution. Continuing antibiotics beyond this point:
- Provides no additional benefit for morbidity or mortality
- Increases risk of antibiotic-associated complications (C. difficile, drug resistance)
- Is not supported by guideline recommendations
The appropriate discharge plan is to stop antibiotics and arrange definitive source control (cholecystectomy) if not already performed 1.